NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi

Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma

(2012) Oskar Koperek et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma

(2012) Georgina V. Long et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A Landscape of Driver Mutations in Melanoma

(2012) Eran Hodis et al.   CELL

Detection of BRAF p.V600E Mutations in Melanomas

(2012) Emeline Colomba et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

(2012) Axel Hauschild et al.   LANCET

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

(2012) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma

(2012) Molly Yancovitz et al.   PLoS One

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

(2011) David Capper et al.   ACTA NEUROPATHOLOGICA

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

(2011) David Capper et al.   ACTA NEUROPATHOLOGICA

IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence

(2010) Lyndee L. Scurr et al.   CELL

Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7—challenging the concept of dysplastic nevi as precursor lesions?

(2010) Kristen DeCarlo et al.   HUMAN PATHOLOGY

The Dermoscopical and Histopathological Patterns of Nevi Correlate with the Frequency of BRAF Mutations

(2010) Iris Zalaudek et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Allelotyping, Microsatellite Instability, and BRAF Mutation Analyses in Common and Atypical Melanocytic Nevi and Primary Cutaneous Melanomas

(2009) Pablo Uribe et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice

(2009) Nathalie Dhomen et al.   CANCER CELL

Progression of NRAS and BRAF Mutations in Cutaneous Melanoma

(2009) Ritchie Rosso et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Lack of Correlation between IGFBP7 Expression and BRAF Mutational Status in Melanoma

(2009) David Schrama et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7

(2008) Narendra Wajapeyee et al.   CELL

Frequencies of NRAS and BRAF Mutations Increase from the Radial to the Vertical Growth Phase in Cutaneous Melanoma

(2008) Victoria R. Greene et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY